Cogo Attention Training Programme is a digital solution provided by Neeuro. Paired with the Neero SenzeBand 2, it encompasses several categories of digital health solutions including Digital Therapeutics (DTx) and DIY Care.

Resources that are helpful in understanding about the Cogo Attention Training Programme includes: Exploring the Potential of Digital Therapeutics (WEBINAR) and A Buyer’s Guide to Digital Therapeutics

Digital Therapeutics​ - Cogo Attention Training Programme

Cogo is a patented, scientifically validated digital therapeutic and attention training programme based on Brain-Computer Interface (BCI) technology, suitable for 6 to 12 years old children who exhibit inattentive symptoms. It is jointly developed by A*STAR’s Institute for Infocomm Research (I2R), Institute of Mental Health, and Duke-NUS Medical School in Singapore through a decade of research and clinical trials. 

Paired with Neeuro SenzeBand 2, the Cogo Attention Training Programme is a 24-session programme. Practitioners can supervise the child's progress either at the clinic or through an online dashboard where the session achievements are tracked. Parents can also receive a progress report as the child completes different sessions. The programme can be completed within 2 to 3 months, at 2 or 3 sessions per week, 30 minutes per session. 

 

Resources that are helpful in understanding about the Cogo Attention Training Programme includes: Exploring the Potential of Digital Therapeutics (WEBINAR) and A Buyer’s Guide to Digital Therapeutics

Neeuro SenzeBand 2​

The Neeuro SenzeBand 2 is a non-invasive device for capturing EEG (brainwaves) signals. It consists of 7 dry electrodes with five located on the prefrontal cortex and two on the sides. Together with Neeuro’s machine learning algorithms, it interprets these EEG signals into various mental states, like attention, relaxation, mental workload, fatigue, stress, and many more. This provides insightful biofeedback for measurements used in real-time to drive interventions for various brain health challenges.

Neeuro is a global company which specialises in the utilisation of Brain Computer Interface technology to maximise the potential of users’ neurological agility and fitness. Neeuro’s extensive portfolio and array of offerings empower digital therapeutics and brain fitness solutions, and are backed with clinically validated research by A*STAR, an institution widely known as being at the forefront of Singapore’s research endeavours. Its core technology, NeeuroOS, is a platform ecosystem that empowers health care professionals, researchers and third party developers with an Artificial Intelligence (AI) driven platform with the ability to analyse the brain signals of users; measuring mental states including but not limited to attention, relaxation, mental workload and fatigue. Neeuro’s holistic platform, coupled with its other offerings, reveal numerous potential avenues to explore complementary mental wellness options for ADHD children, patients with stroke, cognitive rehabilitation and many other neurological issues.

#1 doctor recommended personal EKG. The most clinically validated six-lead personal EKG. It’s a smart device you can trust.

AliveCor has a device and application that will turn any smartphone into a clinical-quality electrocardiogram (ECG) recorder. AliveCor is pioneering the creation of FDA-cleared 'machine learning' techniques to enable proactive heart care and is recognized around the world for transforming cardiac care. The FDA-cleared Kardia Mobile is the most clinically validated mobile ECG solution on the market and is recommended by leading cardiologists and used by people worldwide for accurate ECG recordings. This simple-to-use mobile device and app-based service provides instant analysis for detecting atrial fibrillation (AF) and normal sinus rhythm in an ECG. Kardia Pro is the first AI-enabled platform for doctors to monitor patients for the early detection of atrial fibrillation, the most common cardiac arrhythmia that leads to a five times greater risk of stroke. AliveCor was recognized by Fast Company as one of 2017's most innovative companies in health (#3). AliveCor is a privately-held company headquartered in Mountain View, California.

The child or user's privacy is top priority. There is available dashboard for practitioners to access and track the performance of the child but the names of the individuals need not be divulged.

Dashboard is also available to practitioner anytime, anywhere as it is saved in the cloud with top level security.

Cogo is a cutting-edge Attention Training Programme that utilizes advanced Digital Therapeutics to improve children's attention levels. Unlike other attention training programmes, Cogo utilizes a paired EEG device to measure attention levels, ensuring a personalized, structured, and targeted training programme. 

Emotional

• Gamified approach to provide a fun element to training.​
• A reward system during training that provides positive feedback.

Personal

• Training parameters are personalised and dynamically adjusted.​
• Measured outcomes and transfer effects to academic questions.